Concepedia

Yali Ding

YD

11

Publications

482

Citations

11

H-Index

2014

Active since

Affiliations

Pennsylvania State University(Current)

Loma Linda University

Zhongda Hospital Southeast University

South Central Minzu University

The Ohio State University

Yali Ding is an author at Pennsylvania State University specializing in medicine, gene expression, and cell signaling.

ORCID

Top concepts

Publications per year

2014–2023

11

Publications

11

Dose-effect relationship and molecular mechanism by which BMSC-derived exosomes promote peripheral nerve regeneration after crush injury

Jiu‐Hong Zhao, Yali Ding, Rui He et al. · Stem Cell Research & Therapy · 2020 · 98 citations · Full text

Targeting casein kinase II restores Ikaros tumor suppressor activity and demonstrates therapeutic efficacy in high-risk leukemia

Chunhua Song, Chandrika Gowda, Xiaokang Pan et al. · Blood · 2015 · 95 citations · Full text

IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia

Chunhua Song, Zheng Ge, Yali Ding et al. · Blood · 2020 · 69 citations · Full text

Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia

Haijun Wang, Chunhua Song, Yali Ding et al. · Journal of Biological Chemistry · 2015 · 56 citations · Full text

Ikaros tumor suppressor function includes induction of active enhancers and super-enhancers along with pioneering activity

Yali Ding, Bo Zhang, Jonathon L. Payne et al. · Leukemia · 2019 · 42 citations · Full text

, , +22

Rows per page

1–5 of 11